Status:
UNKNOWN
Physical Rehabilitation in Sickle Cell Anemia
Lead Sponsor:
Centro Universitário Augusto Motta
Conditions:
Sickle Cell Anemia
Muscle Dysfunction
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Sickle cell anemia (SCA) is one of the most neglected diseases worldwide, according to the World Health Organization. In the adult population with SCA, the systemic effects of the disease, such as res...
Detailed Description
Over the past 40 years, Public Health measures have led to an impressive decline in infant mortality related to sickle cell disease (SCA) and, thus, modified its evolution. Sickle cell disease went fr...
Eligibility Criteria
Inclusion
- Patients with sickle cell anemia, of both sexes, aged ≥ 18 years.
- Patients who have clinical stability and are eligible for the treatment protocol.
Exclusion
- Presence of comorbidities not related to sickle cell anemia.
- Patients with inability to perform the six-minute walk test.
- Patients who have cognitive impairment that impairs their inclusion in the study.
- Abandonment of treatment during the application of the protocol.
- Uncontrolled hypertension or use of psychotropic drugs.
- Any significant limitations due to osteoarthropathy.
- Have had any orthopedic surgery in the previous year.
Key Trial Info
Start Date :
January 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04705792
Start Date
January 31 2020
End Date
July 30 2021
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Agnaldo José Lopes
Rio de Janeiro, Brazil, 22745-271